Margaret L. Wolff
About Margaret L. Wolff
Independent Board Member of Nuveen Floating Rate Income Fund (ticker: JFR) and the Nuveen Funds complex since 2016; year of birth 1955; retired Skadden, Arps Mergers & Acquisitions attorney with 30+ years advising boards on governance, fiduciary and strategic matters; B.A. Mt. Holyoke College; J.D. Case Western Reserve University School of Law . She is deemed an Independent Board Member under the 1940 Act, with no employment history at TIAA/Nuveen or affiliates .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Skadden, Arps, Slate, Meagher & Flom LLP (M&A Group) | Of Counsel; senior M&A practitioner advising boards on U.S./international corporate, securities, governance and fiduciary matters | 2005–2014 | Advised boards and senior management on governance, shareholder and regulatory issues . |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| NewYork-Presbyterian Hospital | Trustee | Since 2005 | Ongoing board service . |
| The John A. Hartford Foundation | Trustee; former Chair | Trustee since 2004; Chair 2015–2022 | Philanthropy focused on care for older adults . |
| Mount Holyoke College | Trustee; Vice Chair | Trustee 2005–2015; Vice Chair 2011–2015 | Higher education governance . |
| Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (subsidiaries of The Travelers Companies, Inc.) | Director | 2013–2017 | Prior public-company subsidiary boards in Canada . |
Board Governance
- Independence: Independent Board Member; not an “interested person” of the Funds or adviser; never employed by TIAA/Nuveen or affiliates .
- Years of service: On the Nuveen Funds boards since 2016 .
- Committee assignments:
- Chair: Compliance, Risk Management and Regulatory Oversight Committee .
- Member: Audit Committee (Chair: John K. Nelson; Wolff not designated financial expert), Closed-End Fund Committee .
- Audit “financial expert”: Not designated; committee designees are Moschner, Nelson, Starr, Young .
- Attendance: Each Board Member attended at least 75% of Board and applicable committee meetings during the last fiscal year .
- Meeting load (JFR—Floating Rate Income Fund; last fiscal year):
Meeting Type Count Regular Board 5 Special Board 8 Executive Committee 8 Dividend Committee 8 Compliance, Risk & Reg. Oversight 6 Audit Committee 14 Nominating & Governance 5 Investment Committee 4 Closed-End Fund Committee 4
Fixed Compensation
-
Structure effective Jan 1, 2024 (with increases effective Jan 1, 2025):
Component 2024 Amount 2025 Amount Notes Annual retainer (Independent Board Member) $350,000 $350,000 Base Audit Committee membership $30,000 $35,000 Per member Compliance, Risk Mgmt & Regulatory Oversight membership $30,000 $35,000 Per member Investment Committee membership $20,000 $30,000 Per member Dividend, Nominating & Governance, Closed-End membership $20,000 $25,000 Per member Board Chair $140,000 $150,000 Additional to base Audit or Compliance Committee Chair $30,000 $35,000 Additional to base Investment Committee Chair $20,000 $30,000 Additional to base Dividend, Nominating, Closed-End Chair $20,000 $25,000 Additional to base Ad hoc meeting fee $1,000–$2,500 per meeting $1,000–$2,500 Based on length/immediacy Special assignment committees Chair: ≥$1,250/qtr; Members: ≥$5,000/qtr Same Starting amounts -
Historical (calendar 2023) structure (pre-2024): $210,000 annual retainer plus per-meeting fees (e.g., Audit/Closed-End/Investment $2,500; Compliance $5,000; Dividend $1,250; others $500) and Board Chair $140,000; committee chair retainers $20,000 .
-
Actual compensation received (last fiscal year):
Source Amount From JFR (Nuveen Floating Rate Income Fund) $7,023 Total from funds in the Nuveen Fund Complex $535,644 Deferred fees balance attributable to JFR (Participating Funds plan) $3,051 -
Deferred Compensation Plan: Independent directors may defer compensation; balances notionally track selected Nuveen funds and are paid in lump sum or installments (2–20 years) .
Performance Compensation
- No performance-based compensation, stock awards, or options are disclosed for Independent Board Members; compensation consists of cash retainers/fees and optional fee deferral with no performance metrics .
Other Directorships & Interlocks
| Company/Institution | Role | Committee/Chair Roles | Interlock/Conflict Notes |
|---|---|---|---|
| NewYork-Presbyterian Hospital | Trustee (current) | — | Non-profit; no adviser interlock disclosed . |
| The John A. Hartford Foundation | Trustee (current); Chair 2015–2022 (prior) | Chair (2015–2022) | Non-profit; no adviser interlock disclosed . |
| Mount Holyoke College | Trustee (prior); Vice Chair 2011–2015 (prior) | Vice Chair (2011–2015) | Academic; no adviser interlock disclosed . |
| Travelers Insurance Co. of Canada; Dominion of Canada General Insurance Company (Travelers Canada) | Director (2013–2017, prior) | — | Prior subsidiary boards; no current conflicts disclosed . |
- Related-party exposures: The proxy lists board members with securities in companies advised by affiliates; Wolff is not listed among those with such holdings; no related-party transactions for Wolff disclosed .
Expertise & Qualifications
- M&A and corporate governance expert; extensive experience advising boards on fiduciary duties, shareholder issues, regulatory and strategic matters .
- Chair of the board’s Compliance, Risk Management and Regulatory Oversight Committee; active oversight of enterprise risk, leverage, derivatives, liquidity and CCO reporting .
- Audit Committee member (not designated as “audit committee financial expert”) .
Equity Ownership
| Measure | JFR (Floating Rate Income) | Fund Complex Aggregate |
|---|---|---|
| Shares owned (12/31/2024) | 0 | — |
| Dollar range in JFR | $0 | — |
| Aggregate range across family of registered investment companies overseen | — | Over $100,000 |
| % of shares outstanding | <1% for each Board Member individually | <1% as a group for each Fund |
- Ownership alignment principle: Each Board Member is expected to invest at least the equivalent of one year of compensation in Nuveen Funds in the Fund Complex (directly or via deferral); only dollar ranges are disclosed, not precise compliance status .
Governance Assessment
-
Positives
- Independent director with deep M&A/governance expertise; chairs the Compliance Committee overseeing risk, compliance, leverage and derivatives—central to a leveraged income CEF .
- Active committee workload (Audit, Compliance Chair, Closed-End Fund Committee) and disclosed attendance at or above 75% threshold amid heavy meeting cadence (e.g., 14 Audit meetings for JFR last fiscal year) supports engagement .
- No disclosed related-party transactions or affiliate-advised private holdings for Wolff; not listed in affiliate-ownership appendix .
-
Watch items / RED FLAGS
- No direct ownership in JFR as of 12/31/2024 (dollar range $0; shares 0), which may weaken fund-specific alignment, though she reports aggregate investments “Over $100,000” across the family of funds .
- Aggregate director compensation from the Nuveen Fund Complex is material ($535,644), typical for complex-wide fund boards, but can heighten perceived reliance on board fees; monitor ongoing independence disclosures and workload balance .
- Ad hoc/special assignment fees remain in structure and could, at the margin, incentivize additional meetings; the 2024 shift to annual retainers mitigates per-meeting incentives relative to 2023 .
-
Independence & elections
- All nominees/current board members, including Wolff, are Independent under the 1940 Act; Wolff is a current nominee in various funds’ Class I slates per the proxy .